AlphAIalphai — Financial news for AI agents
SEC EDGARJUL 302 min read$GL

Kalmbach Thomas Peter sold $3.8M of GL

Kalmbach Thomas Peter (EVP & CFO) sold 21,000 shares of GLOBE LIFE INC. (GL) at an average of $180.06 ($179.30–$181.81, $3.78M total) across 4 trades on 2026-07-30.

Original reporting
SEC EDGAR · Kalmbach Thomas Peter
Published Jul 30, 2026, 10:14 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 30, 2026, 10:17 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
alphai market briefInsider activity
Primary signal
$GL
Neutral
medium confidence
Mentioned
$GL
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$GLNeutralLow
01

Why it matters

The disclosed open-market sale is a sentiment datapoint for GL but lacks accompanying company-specific news (earnings, guidance, deals, or regulatory actions).

02

Market read

Traders may briefly reassess GL sentiment due to CFO selling, but the filing alone is unlikely to drive a durable repricing without additional fundamental catalysts.

03

What to watch

The filing does not state a 10b5-1 plan, so traders may over-interpret intent; also, the article provides no context on prior grants, compensation timing, or planned liquidity needs.

Relevance 6/10Novelty 3/10Timing: filed 2026-07-30, reflects same-day insider sale

Background

The article is a Form 4 insider transaction disclosure for Globe Life Inc. (GL) by its EVP and CFO.

Company-level read

Ticker impact

$GLNeutralMedium confidence
Context

Kalmbach Thomas Peter, GL’s EVP and CFO, sold about 21,000 shares on 2026-07-30 for roughly $3.78M total value.

Expected impact

Likely limited, short-lived sentiment impact; watch for follow-on insider activity or unusual volume.

Evidence & confidence

Form 4 discloses the sale size, price range, and post-transaction holdings, but provides no new operational, financial, or regulatory information.

Market effects

Sector

No sector-level signal; this is company-specific insider transaction data.

Regional

None indicated.

Global

None indicated.

Counterpoint

What could challenge this read

Insider sales can be tax- or diversification-driven and do not necessarily imply bearish fundamentals, especially when the sale is spread across multiple trades.

Key entities

  • issuer
    Globe Life Inc.

    Subject of the Form 4 insider transaction disclosure.

  • insider
    Kalmbach Thomas Peter

    EVP and CFO who sold shares on 2026-07-30.

Read at source← All news

Related articles

JUL 25
$GLMedAI 8/10

Globe Life Boosts EPS Outlook Following Strong Q2 Earnings

Globe Life Inc. reported Q2 net income of $288 million, or $3.65 per share, up 20% year over year, and net operating income of $285 million, or $3.61 per share, up 10%. The insurer cited underwriting strength and excess investment returns and raised full-year guidance to 2026 net operating EPS of $15.55-$15.95 and share repurchases of $670M-$700M.

sekbernews.id4 min
JUL 23
$GLMed

Why Globe Life (GL) Shares Are Sliding Today

Globe Life (NYSE: GL) shares fell about 7% after its Q2 results met Wall Street estimates but did not provide upside. Revenue rose 6.7% to about $1.6B and net premiums earned were about $1.30B. GAAP EPS was $3.65 vs $3.64 expected. The stock closed at $170.96.

financialcontent.com6 min
JUL 23
$GLMedAI 8/10

Full Transcript: Globe Life Q2 2026 Earnings Call - Globe Life (NYSE:GL)

Globe Life Inc. (NYSE:GL) reported Q2 2026 net income of $288 million, or $3.65 per share, up 20% year over year, and net operating income of $285 million, or $3.61 per share, up 10%. Premium revenue rose 7% (life +3%, health +16%). The company repurchased $175 million of shares and guided full-year net operating EPS growth of 8.5%.

benzinga.com10 min
JUL 23
$GLMedAI 8/10

Globe Life Q2 Earnings Call Highlights

Globe Life (NYSE:GL) reported Q2 health premium revenue up 16% to $437M and health underwriting margin up 1% to $99M, though the margin fell to about 23%. Life policy obligations improved. Management raised 2026 net operating EPS guidance to $15.55 to $15.95 and increased buybacks. The company repurchased ~1.1M shares for $175M in Q2.

finance.yahoo.com6 min
JUL 23
$GLMedAI 8/10

Why is Globe Life stock sliding today? By Investing.com

Globe Life shares fell 8.1% after its Q2 2026 results. Net operating income was $3.61 per diluted share versus $3.67 consensus, while revenue was $1.60B versus $1.59B. Full-year 2026 EPS guidance was raised to $15.55-$15.95 but the midpoint ($15.75) stayed below $15.65 consensus, alongside insider net selling and a risk-off market.

investing.com4 min
JUL 22
$GLMed

GLOBE LIFE INC. (GL): Results of Operations and Financial Condition

GLOBE LIFE INC. (GL) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 q2fy2026earningsrelease.htm EX-99.1 Document GLOBE LIFE INC. REPORTS Second Quarter 2026 Results McKinney, TX, July 22, 2026 —Globe Life Inc. (NYSE: GL) reported today that for the quarter ended June 30, 2026, net income was $3.65 per diluted common share, compared with

SEC EDGAR 8-K6 min